Stamford, CT -- (SBWIRE) -- 01/25/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Phoenix New Media Ltd ADR (NYSE:FENG), PMC-Sierra Inc (NASDAQ:PMCS), BioScrip Inc (NASDAQ:BIOS), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
Phoenix New Media Ltd ADR (NYSE:FENG) opened the session at $10.45, trading in a range of $9.78 - $10.48. The stock showed a negative performance of -5.64% in the last trading session from its previous close of $10.64 and closed at $10.04. The stock traded on a volume of 1.73 million shares and the average volume of the stock remained 1.04 million shares. Phoenix New Media Limited (PNM) is a new media company providing content on an integrated platform across Internet, mobile and television (TV) channels in China. PNM enables consumers to access professional news and other content and share user-generated content (UGC), on the Internet and through their mobile devices. The Company also transmits its UGC and in-house produced content to TV viewers primarily through Phoenix TV.
Has FENG Found The Bottom and Ready To Move Up? Find Out Here
PMC-Sierra Inc (NASDAQ:PMCS) traded 1.73 million shares in the last business day while the average volume of the stock remained 1.40 million shares. The stock showed a negative movement of -3.05% to end at $6.35. The 52 week range of the stock remained $5.53 - $7.14. PMC-Sierra, Inc., is a semiconductor innovator transforming networks that connect, move and store digital content. The Company designs, develops, markets and supports semiconductor solutions by integrating its mixed-signal, software and systems through a network of offices in North America, Europe and Asia.
Has PMCS Found The Bottom And Ready To Gain Momentum? Find Out Here
BioScrip Inc (NASDAQ:BIOS) reported 1.69 million shares were exchanged during the last trade, while the average volume is about 1.33 million shares. The stock dropped -1.43% and finished the day at $8.27. The beta of the stock is recorded at 1.45. BioScrip, Inc. (BioScrip) is a provider of pharmacy and home health services, which partners with patients, physicians, hospitals, healthcare payors and pharmaceutical manufacturers to provide clinical management solutions and the delivery of prescription medications and home health services. Its platform provides service capabilities and the ability to deliver clinical management services, which offers patients a community-based and home-based care environment. I
Why Should Investors Buy BIOS After the Recent Fall? Just Go Here and Find Out
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares dropped -4.68 percent from its previous close of $12.17 to close at $11.60. Traded with volume of 1.68 million shares in the prior session and the average volume of the stock remained 1.34 million shares. BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company. BioCryst designs, optimizes and develops drugs that block enzymes involved in the pathogenesis of diseases. The Company focuses on therapeutic areas. Peramivir is its product, which is a neuraminidase inhibitor for the treatment of patients with influenza. The Company has two purine nucleoside phosphorylase (PNP) inhibitors that are in development, BCX4208 for the treatment of gout and forodesine for the treatment of hematological malignancies.
Will BCRX Get Buyers Even After The Recent Rally? Find Out Here
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)